Information indicates that on June 18, the Hong Kong Stock Exchange disclosed a listing application from Cspc Innovation Pharmaceutical Co.,Ltd. (300765.SZ), targeting the Main Board, with CITIC Securities serving as its exclusive sponsor. The company had previously submitted an application for listing on December 10, 2025. According to the prospectus, data from Frost & Sullivan shows that from 2020 to 2025, Cspc Innovation Pharmaceutical Co.,Ltd. maintained its position as the world's largest producer of chemically synthesized caffeine by revenue and shipment volume. The company's primary product is caffeine used as a food additive in functional beverages.
Comments